Evidence map›Paper›PMID 37842641›Full record

ArticleFrontiers in molecular biosciences2023

Purification of linearized template plasmid DNA decreases double-stranded RNA formation during IVT reaction.

Juan Martínez, Verónica Lampaya, Ana Larraga, Héctor Magallón, Diego Casabona

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 36 citations in OpenAlex.

  1. Towards mRNA therapeutics 2.0.Nature reviews. Drug discovery · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Understanding the impact ofFrontiers in molecular biosciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Juan MartínezRNA Synthesis and Development Department, Certest Pharma, Certest Biotec, Zaragoza, Spain.
Verónica LampayaRNA Synthesis and Development Department, Certest Pharma, Certest Biotec, Zaragoza, Spain.
Ana LarragaRNA Synthesis and Development Department, Certest Pharma, Certest Biotec, Zaragoza, Spain.
Héctor MagallónRNA Synthesis and Development Department, Certest Pharma, Certest Biotec, Zaragoza, Spain.
Diego CasabonaRNA Synthesis and Development Department, Certest Pharma, Certest Biotec, Zaragoza, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

After the COVID-19 pandemic, messenger RNA (mRNA) has revolutionized traditional vaccine manufacturing. With the increasing number of RNA-based therapeutics, valuable new scientific insights into these molecules have emerged. One fascinating area of study is the formation of double-stranded RNA (dsRNA) during

Indexed as

chromatographydsRNAimmunogenicityIVTmRNApolishingvaccines

Identifiers

PMID37842641
PMCPMC10570549
OpenAlexW4387165882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.